Literature DB >> 3806893

Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness.

K L MacDonald, M T Osterholm, C W Hedberg, C G Schrock, G F Peterson, J M Jentzen, S A Leonard, P M Schlievert.   

Abstract

Nine cases of severe hypotension or death compatible with toxic shock syndrome (TSS) as a complication of influenza and influenzalike illness were identified in Minnesota with onsets between Jan 2, 1986, and Feb 23, 1986, in which five of the patients died. During this time, an influenza outbreak was occurring in the state. Cultures of respiratory secretions were performed in eight patients; Staphylococcus aureus was isolated from all of them. Seven S aureus isolates were available for determination of exotoxin production; five isolates produced toxic shock syndrome toxin-1, one produced enterotoxin B, and one produced both. Acute influenza B infection was confirmed in three of four patients for whom throat cultures or acute and convalescent serum samples were available. Two patients fulfilled the Centers for Disease Control-confirmed case definition for TSS. Four additional patients fulfilled the CDC criteria for a probable case of TSS, and TSS was a likely diagnosis in the remaining three patients. The initial presentation was suggestive of nonsuppurative tracheitis or viral pneumonia in eight patients. In the remaining patient, the initial clinical presentation was compatible with staphylococcal pneumonia. This report demonstrates that TSS can occur as a complication of influenza and influenzalike illness.

Entities:  

Mesh:

Year:  1987        PMID: 3806893     DOI: 10.1001/jama.257.8.1053

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  59 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis.

Authors:  M L Sion; A I Hatzitolios; E N Toulis; K D Mikoudi; G N Ziakas
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

3.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

5.  Bacterial tracheitis associated with respiratory syncytial virus infection and toxic shock syndrome.

Authors:  C Nijssen-Jordan; J D Donaldson; S A Halperin
Journal:  CMAJ       Date:  1990-02-01       Impact factor: 8.262

6.  Toxic shock syndrome presenting as an acute encephalopathy and diarrhoea.

Authors:  S R Hanafiah; S K Chong
Journal:  J R Soc Med       Date:  1991-01       Impact factor: 5.344

7.  Activation of common antiviral pathways can potentiate inflammatory responses to septic shock.

Authors:  Lesley A Doughty; Stacey Carlton; Benjamin Galen; Indranie Cooma-Ramberan; Chung-Shiang Chung; Alfred Ayala
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

8.  Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.

Authors:  J Tseng; J L Komisar; R N Trout; R E Hunt; J Y Chen; A J Johnson; L Pitt; D L Ruble
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 9.  Sudden unexpected nocturnal deaths among Thai immigrant workers in Singapore. The possible role of toxigenic bacteria.

Authors:  C C Blackwell; A Busuttil; D M Weir; A T Saadi; S D Essery
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 10.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.